Home > Insider Trading > Filing (0001104659-23-037129)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1708527	Aziyo Biologics Inc.	AZYO	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1377832	Matthew Strobeck	688 Pine Street, Suite D Burlington VT 05401	No	No	Yes	No
1603544	Birchview Fund Llc	688 Pine Street, Suite D Burlington VT 05401	No	No	Yes	No
1618205	Birchview Capital, Lp	688 Pine Street, Suite D Burlington VT 05401	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2023-03-23	100,000	$1.49	1,615,184	No	4	P	Indirect	See footnote
Class A Common Stock	Acquisiton	2023-03-23	10,000	$1.49	1,625,184	No	4	P	Indirect	See footnote
Class A Common Stock	Acquisiton	2023-03-24	18,000	$1.35	1,643,184	No	4	P	Indirect	See footnote
Class A Common Stock	Acquisiton	2023-03-24	2,000	$1.35	1,645,184	No	4	P	Indirect	See footnote
Class A Common Stock	Acquisiton	2023-03-27	10,000	$1.59	1,655,184	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote

Footnotes

Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC ("the Fund"). Birchview Capital, LP is the investment manager of the Fund.
The Fund acquired the shares as specified in Table I. As investment manager of the Fund, Birchview Capital, LP possesses the power to vote and dispose or direct the disposition of the shares acquired by the Fund.
As specified in Table I, Birchview Capital, LP advises the acquired shares in a separately managed account ("SMA").
As specified in Table I, Birchview Capital, LP advises the acquired shares in a different SMA other than the one noted above.